1. Cincinnati Children's Hospital Medical Center (11 from 413 patents)

2. Instituto Nacional De Ciencias Medicas Y Nutricion (10 from 10 patents)

3. The General Hospital Corporation (9 from 2,893 patents)

4. Glycosyn LLC (4 from 20 patents)

5. Johns Hopkins University (2 from 3,688 patents)

6. University of Massachusetts (2 from 1,556 patents)

7. The Trustees of Boston College (2 from 111 patents)

8. Cancer Research Fund of Contra Costa (2 from 12 patents)

9. Senomed, Inc. (2 from 2 patents)

1. 12171773 - Inhibiting inflammation with milk oligosaccharides

2. 11331329 - Fucosylated oligosaccharides for prevention of coronavirus infection

3. 11324766 - 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation

4. 11324765 - Inhibiting inflammation with milk oligosaccharides

5. 11058697 - Inhibiting inflammation with milk oligosaccharides

6. 10286001 - Use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics

7. 10098903 - Inhibiting inflammation with milk oligosaccharides

8. 9567361 - Use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics

9. 9132142 - Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease

10. 9132143 - Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease

11. 9034847 - Inhibiting inflammation with milk oligosaccharides

12. 8574850 - Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease

13. 8314061 - Adiponectin for treatment of various disorders

14. 7893041 - Oligosaccharide compositions and use thereof in the treatment of infection

15. 7871785 - Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease